Cargando…
The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250894/ https://www.ncbi.nlm.nih.gov/pubmed/34510834 http://dx.doi.org/10.1002/hep4.1736 |
| _version_ | 1783717075101941760 |
|---|---|
| author | Shen, Yue Eades, William Yan, Bingfang |
| author_facet | Shen, Yue Eades, William Yan, Bingfang |
| author_sort | Shen, Yue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8250894 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82508942021-07-02 The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity Shen, Yue Eades, William Yan, Bingfang Hepatol Commun Correspondence John Wiley and Sons Inc. 2021-07-16 /pmc/articles/PMC8250894/ /pubmed/34510834 http://dx.doi.org/10.1002/hep4.1736 Text en © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Shen, Yue Eades, William Yan, Bingfang The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title | The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title_full | The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title_fullStr | The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title_full_unstemmed | The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title_short | The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity |
| title_sort | covid‐19 medicine remdesivir is therapeutically activated by carboxylesterase‐1, and excessive hydrolysis increases cytotoxicity |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250894/ https://www.ncbi.nlm.nih.gov/pubmed/34510834 http://dx.doi.org/10.1002/hep4.1736 |
| work_keys_str_mv | AT shenyue thecovid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity AT eadeswilliam thecovid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity AT yanbingfang thecovid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity AT shenyue covid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity AT eadeswilliam covid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity AT yanbingfang covid19medicineremdesiviristherapeuticallyactivatedbycarboxylesterase1andexcessivehydrolysisincreasescytotoxicity |